Download our 8 page newsletter, produced in association with LivaNova
Category: Sponsored Feature
The Missing Pieces: Identifying the gaps in care and conversations in MS
Developed and funded by Sanofi Genzyme
Sponsored Article
STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common…
In Parkinson’s disease, patients may suffer from delayed ON as well as wearing OFF – which is more important?
Report from Britannia Pharmaceuticals on their plenary session on PD treatment, held at the 9th CONy Congress in Budapest, Hungary, March 2015
10th European Paediatric Neurology Society Congress
Highlights of a satellite symposium held at the 10th European Paediatric Neurology Society Congress, 25–28 September 2013, Brussels, Belgium
XI World Congress of Neurology
Spotlight on epilepsy management: focussing on the needs of the individual patient
Latest implantable and external neurostimulation technology for drop foot correction and gait rehabilitation
Michael Jauch
